Inversago Pharma
Latest round
- Series C
Last raised
- Oct 2022
Total raised
- $111M
Investors
- 12
About Inversago Pharma
Founded in 2015 and headquartered in Montréal, Canada, Inversago Pharma Inc. focuses on developing therapies for metabolic disorders and fibrotic conditions.075 billion.Inversago Pharma specializes in developing peripherally acting CB1 receptor (CB1r) blocker therapies aimed at addressing complications related to metabolic and fibrotic diseases. Its lead product, INV-202, is being evaluated in two Phase 2 clinical studies targeting diabetic kidney disease and obesity, aiming to regulate peripheral CB1 receptors linked to various metabolic conditions.Inversago Pharma's revenue model relies on collaborations and partnerships with larger pharmaceutical firms for the development and commercialization of its therapies.075 billion, Inversago Pharma plans to leverage this investment to bolster its clinical development pipeline, particularly in obesity and related disorders. The funds are expected to facilitate the progression of INV-202 and other compounds in development, with strategic initiatives aimed at expanding market reach in both established and emerging markets.
Who invested in Inversago Pharma
12 investors across 3 rounds
See all investors in Inversago Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Inversago Pharma
Who invested in Inversago Pharma?
Inversago Pharma has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inversago Pharma raised?
Inversago Pharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Inversago Pharma last raise money?
Inversago Pharma's most recent round on record is a Series C, in Oct 2022.
What does Inversago Pharma do?
Founded in 2015 and headquartered in Montréal, Canada, Inversago Pharma Inc.
Where is Inversago Pharma headquartered?
Inversago Pharma is headquartered in Montréal, Canada.
Which VCs invest in companies like Inversago Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Inversago Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Inversago Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.